CAS: 50632-53-6; N-Isopropylhydroxylamine Hydrochloride

该化合物是一种氢氧胺衍生物,通常用作有机合成的减少剂和中间剂.其主要优点包括减少还原剂和硝化物组的高度反应性,使其在制药和农用化学应用中具有价值.盐的盐形式增强了水溶剂和极地溶剂的稳定性和溶解性,便利了处理和储存.化合物的选择性减少特性有助于保护组化学和聚合物的稳定.其明确界定的结构和持续纯度确保了研究和工业过程的可复制结果.由于它可能具有对湿度和热度的敏感性,需要妥善处理.

结构式图片

相似化合物

57497-39-9 16649-50-6 15572-56-2

欧盟法规

ECHA物质C&L通报

上下游产品

CAS号79-46-9 2-硝基丙烷 | CAS号61077-22-3 N-hydroxy-N-pro...

合成工艺路线路线简述

    二异丙胺置于双氧水,盐酸体系中,用 甲醇,水 作为反应溶剂,40.0~60.0 °C,15.0 Kpa 条件下,反应 12.0H,反应生成 N-异丙基羟胺盐酸盐
    参考文献: Process For The Purification Of A Mixture Comprising N-Alkyl-Hydroxylammonium Salts[fr] Procédé De Purification D'Un Mélange Comprenant Des Sels De N-Alkyl-Hydroxylammonium
    标题: Process For The Purification Of A Mixture Comprising N-Alkyl-Hydroxylammonium Salts[fr] Procédé De Purification D'Un Mélange Comprenant Des Sels De N-Alkyl-Hydroxylammonium
    摘要:本发明涉及一种纯化包含水,N-烷基-羟胺盐和一些副产物的混合物的方法,其中从混合物中蒸馏出水和副产物,直到残渣中n-烷基-羟胺盐的纯度达到95%或更高,并在蒸馏过程中和之后保持水含量>=40重量百分比.

    专利信息


    专利号:US-2005192265-A1
    优先权日:2003-03-20
    标 题:Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds
    发明人:THOMPSON RICHARD C; WILKIE STEPHEN; STACK DOUGLAS R; VANMETER ELDON E; SHI QING; BRITTON THOMAS C; AUDIA JAMES E; REEL JON K; MABRY THOMAS E; DRESSMAN BRUCE A; CWI CYNTHIA L; HENRY STEVEN S; MCDANIEL STACEY L; STUCKY RUSSELL D; PORTER WARREN J
    摘要:Disclosed are compounds which inhibit β-amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease. Also disclosed are pharmaceutical compositions that include a compound which inhibits β-amyloid peptide release and/or its synthesis as well as methods for treating Alzheimer's disease both prophylactically and therapeutically with such pharmaceutical compositions.

    专利号:US-6906056-B2
    优先权日:1998-06-22
    标 题:Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
    发明人:THOMPSON RICHARD C; WILKIE STEPHEN; STACK DOUGLAS R; VANMETER ELDON E; SHI QING; BRITTON THOMAS C; AUDIA JAMES E; REEL JON K; MABRY THOMAS E; DRESSMAN BRUCE A; CWI CYNTHIA L; HENRY STEVEN S; MCDANIEL STACEY L; STUCKY RUSSELL D; PORTER WARREN J
    权利人:LILLY CO ELI
    摘要:Disclosed are compounds which inhibit β-amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease. Also disclosed are pharmaceutical compositions that include a compound which inhibits β-amyloid peptide release and/or its synthesis as well as methods for treating Alzheimer's disease both prophylactically and therapeutically with such pharmaceutical compositions.

    专利号:US-7468375-B2
    优先权日:2004-04-26
    标题:Inhibitors of the HIV integrase enzyme
    发明人:DRESS KLAUS RUPRECHT; HU QIYUE; JOHNSON TED WILLIAM; PLEWE MICHAEL BRUNO; TANIS STEVEN PAUL; WANG HAI; YANG ANLE; YIN CHUNFENG; ZHANG JUNHU
    权利人:PFIZER
    摘要:The present invention is directed to compounds of formula (I), and pharmaceutically acceptable salts and solvates thereof, their synthesis, and their use as modulators or inhibitors of the human immunodeficiency virus (“HIVâ€?) integrase enzyme.

    专利号:US-2004106598-A1
    优先权日:1998-06-22
    标 题:Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting Beta-amyloid peptide release and/or its synthesis by use of such compounds

    专利号:US-2005192269-A1
    优先权日:1998-06-22
    标 题:Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds

    专利号:US-2005267150-A1
    优先权日:1998-06-22
    标 题:Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds
    郑州今斯孚化学有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.kingsfine.com/index.html
    电话: 0371-56632527 13838252817👤
    📞郑州今斯孚化学有限公司 ⚠️参考联系方式

    销售电话:0371-56632527 13838252817
    邮箱:sales@kingsfine.com
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    上海凌凯医药科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.linkchem.cn
    企业联系电话:021-58950110;13124863828👤
    📞上海凌凯医药科技有限公司 ⚠️参考联系方式
    联系人:张经理
    电话:021-58950110;13124863828
    手机:13124863828
    传真:021- 2096 2272
    邮箱:sales@linkchem.cn
    通信地址: 上海市浦东新区国际医学园区康新公路3399弄5号楼
    邮编: 201204
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:上海市浦东新区国际医学园区康新公路3399弄5号楼
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    参考文献:10.1007/s00216-006-0495-1
    摘要:Yi L, Dratter J, Wang C, Tunge JA, Desaire H. Identification of sulfation sites of metabolites and prediction of the compounds’ biological effects. Analytical and Bioanalytical Chemistry. 2006 May 25;386(3):666–74. doi: 10.1007/s00216-006-0495-1.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知